Erratum for Peroutka-Bigus et al., “Contribution of front-line, standard-of-care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis disease”
Nathan Peroutka-Bigus, Elizabeth J. Brooks, Michelle E. Ramey, Hope D’Erasmo, Jackie P. Ernest, Allison A. Bauman, Lisa K. Woolhiser, Radojka M. Savic, Anne J. Lenaerts, Bree B. Aldridge, Jansy P. Sarathy, Gregory T. Robertson
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Fig 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTuberculosis Research and Epidemiology
ERRATUM
Volume 69, no. 5, e01901-24, 2025, https://doi.org/10.1128/aac.01901-24. Page 2: Fig. 1E should appear as shown in this erratum. The number of mice relapsing at M4 + 3 was entered correctly but the accompanying percentage was incorrect and has been updated. The erratum does not change the conclusions of the original publication.
**